Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Bogani et al

Int J Gynecol Cancer. 2024 Oct 7;34(10):1659. doi: 10.1136/ijgc-2024-005958.

Ana Luzarraga Aznar¹, Vicente Bebia², Silvia Cabrera^{3

4}

¹ Gynecologic Oncology Unit, Gynecology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain aluzarraga7@gmail.com.
² Gynecologic Oncology Unit, Gynecology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
³ Gynecologic Oncology Unit, Obstetrics and Gynecology Department, Hospital de la Santa Creu i Sant Pau Servei d'Obstetricia i Ginecologia, Barcelona, Spain.
⁴ Obstetrics and Gynecology Department, Hospital Universitari General de Catalunya, Barcelona, Catalunya, Spain.

No abstract available

Keywords: Endometrial Neoplasms; Sentinel Lymph Node; Surgical Oncology.

Publication types